NSW Health published a media release on 12 September 2024 urging pregnant women, parents and carers of babies, grandparents and other people in close contact with babies to be vaccinated against pertussis (whooping cough) to protect babies from severe disease.
The latest data shows that notifications of whooping cough are at their highest level since 2016, with over 12,000 cases reported in NSW from January to September 2024.
Pregnant women are recommended to be vaccinated between 20 and 32 weeks of every pregnancy as this enables whooping cough antibodies to be transferred to their unborn baby.
All people in contact with newborn babies are recommended to have had a pertussis vaccine within the previous 10 years.
Mpox important updates
Call out to s100 prescribers to deliver mpox vaccination
Mpox vaccination is a critical step in reducing the spread of the virus, particularly among high-risk populations. As trusted healthcare providers, general practitioners and nurse immunisers play a vital role in protecting their communities by offering this vaccine. We urge you to begin vaccinating eligible patients and raising awareness about mpox prevention. Your proactive efforts can significantly reduce transmission and protect vulnerable individuals.
To assist in access to mpox vaccination, all s100 prescribers are invited to receive NSW Health funded Jynneos vaccine for their eligible patients. If you would like to receive Jynneos vaccine please contact your local public health unit on 1300 066 055.
All sexually active gay and bisexual men (cis and trans).
Sex workers.
Sexual partners of the people above.
People who have been in contact with mpox
Mpox vaccination is free and a Medicare card is not needed at the clinics listed here. Local clinics include:
RPA Sexual Health Clinic, Camperdown
Kirketon Road Centre, Darlinghurst
Short Street Centre Sexual Health Clinic, St George Hospital, Kogarah
The Albion Centre, Surry Hills
Sydney Sexual Health Clinic, Sydney & Sydney Eye Hospital
RPA HealthOne Green Square, Zetland
Yellow Fever course update
From 1 October 2024, the Yellow Fever Vaccination Learning and Accreditation Course (formerly the Yellow Fever Vaccination Course) will be hosted by the Interim Australian Centre for Disease Control. The content of the course has not changed. The yellow fever vaccination course link will be accessible on the Department’s yellow fever webpage from 1 October 2024.
Practitioners who previously completed the course on the Australian College of Rural and Remote Medicine (ACRRM) website, will still be able to access their course completion certificate, however the course itself will no longer be hosted on the ACRRM website after 30 September 2024. Completion certificates awarded by ACRRM remain valid until the expiry date specified on the certificate.
Individual practitioners must complete the Yellow Fever Vaccination and Accreditation Course every three years to prescribe the yellow fever vaccine in Australia.
For further information on the new hosting arrangement, please contact the department’s Yellow Fever Vaccination Learning and Accreditation Course team at yellowfevercourse@health.gov.au.
Provider update on COVID-19 vaccines
The following COVID-19 vaccine formulations are no longer available to order on CVAS:
Moderna (XBB.1.5) 12 years+ PFS vaccine – all stock nowexpired
Pfizer Bivalent (BA.4-5) 12 years + (Grey) (ancestral formulation) – all stock nowexpired
Pfizer 6 months to 4 years (Maroon)vaccine (ancestral formulation) – due to expire 30 September 2024
Sites are reminded not to administer any expired vaccines beyond their use-by date and must discard any remaining stock and ensure that it is reported as wastage in CVAS.
Vax at home program ceasing 30 September 2024
The Vax at Home Program was introduced in 2021 during the COVID-19 global pandemic. Throughout the existence of the program, CESPHN along with its providers have supported the most vulnerable people in our community, delivering nearly 700 COVID-19 vaccinations to housebound patients and close to 9,000 vaccinations to residents in residential aged care homes.
The Vax at Home Program will be ceasing at the end of September 2024. The last day for GP referrals for housebound patients that need a COVID-19 vaccine or booster, will be Wednesday, 18 September 2024. Further information can be found here.
Video resources for childhood immunisation
Browse the Department’s video resources from the ‘One more way you keep them safe’ campaign on childhood immunisation. Video collection includes:
Schedule and tips: Learn more about the schedule and tips for childhood immunisation.
Videos for expectant parents: Expectant parents can learn about the safety of vaccines, how they for work for pregnancies and newborns, immunisation tips and more.
Case study videos: Hear from other parents about their experiences with routine childhood immunisations.
Webinar: Navigating Mpox and Doxy-PEP in your practice
This RACGP webinar focuses on the current epidemiology of mpox, transmission risks, managing clinical presentations, differential diagnoses, and testing, along with the latest vaccination recommendations.
Webinar: Pre-travel health & travel vaccination recommendations
This lunch and learn webinar, presented by a Nurse Practitioner, will cover how to deliver a pre-travel health consultation including vaccination recommendations and pre-travel health advice for travellers based on travel itinerary.
Target audience: GPs, nurses, practice staff, practice managers, pharmacists and AHPs
Hybrid event: Immunisation For Health And Life Immunisation Coalition presents this hybrid event specifically designed for General Practitioners and Nurses who immunise/vaccinate against infectious diseases.
Topics include addressing vaccine hesitancy/fatigue, diagnosis and management of long COVID-19, vaccination errors, influenza and RSV, Q-fever, tools to recall under vaccinated patients, equity of vaccines, and a debate on whether monoclonal antibodies should be added to the NIP?
Onsite attendance is limited to 100 seats, while online participation is unlimited.
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update read about: Updated: RSV FAQs Scholarships available: ANI course Education Updated: RSV FAQs NCIRS’ respiratory syncytial virus (RSV) FAQs have been updated this week to reflect the growing availability of the long-acting monoclonal antibody Beyfortus (nirsevimab) for…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update read about: Pertussis (whooping cough) is at highest rate in 15 years Expansion of Shingrix eligibility Scholarships available: ANI course New ‘Recommended sites for childhood vaccinations’ poster Pneumococcal updates Education available. Pertussis (whooping cough) is at highest…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update read about: Whooping cough infections on the rise Mpox important updates Yellow Fever course update Provider update on COVID-19 vaccines Vax at home program ceasing 30 September 2024 Video resources for childhood immunisation Education Whooping cough infections…
Immunisation Weekly Update: Welcome to our weekly Immunisation Update! In this week’s update read about: Mpox important updates Childhood immunisation coverage data by PHN and SA3 New ‘Recommended sites for childhood vaccinations’ poster New ‘Super Kids’ childhood vaccination campaign Updated COVID-19 resources Mpox important updates Mpox transmission is increasing in…
Immunisation Weekly Update: Shingrix® NIP eligibility expansion Shingrix vaccination data New Handbook infographic for Pneumococcal Transition from QIV to TIV influenza vaccine Webinar: Pertussis Update Shingrix® NIP eligibility expansion From 1 September 2024, free shingles vaccination under the National Immunisation Program (NIP) will be expanded to include people at moderate to…